ERBB2 and breast cancer: The Cox prognostic model indicated that a plasma HER2 ratio of ≥1.41 was an adverse prognostic factor in patients with advanced breast cancer (HR = 1.90, 95% CI: 1.13 to 2.52, p < 0.01, shown in Table 2).